Modified virus tested as new weapon against tough cancers
Disease control
Recruiting now
This is an early-stage study to test the safety of a new cancer treatment called VG2062. The treatment uses a modified herpes virus designed to target and kill cancer cells. The study will enroll about 30 adults with advanced solid tumors that have stopped responding to standard …
Phase: PHASE1 • Sponsor: Shanghai Virogin Biotech Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC